High-Sensitivity Cardiac Troponin I and Clinical Outcomes of Major Acute Cardiac Events
The Journal of Applied Laboratory Medicine · 01.07.2026 · 11 (4) · 696-708
DOI: 10.1093/jalm/jfag035 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 28.04.2026. Verfasst von Michelle N Steiner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Science, University of Texas Medical Branch, Galveston, TX, United States. Hauptthemen laut MEDLINE: Troponin I, Acute Coronary Syndrome, Myocardial Infarction. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The long-term benefit of sex-specific 99th percentile upper reference limits (URLs) in conjunction with high-sensitivity cardiac troponin assays for suspected acute coronary syndrome (ACS) are emerging. We evaluated the long-term outcomes of patients reclassified by this approach using the Beckman Coulter Access high-sensitivity troponin I (hs-cTnI) assay.
Methods
A retrospective observational study evaluated 1486 emergency department (ED) patients with hs-cTnI results for 3 years and 80 days. Patients whose values exceeded the sex-specific URL but remained below the conventional URL were identified and compared with non-reclassified controls.
Results
Reclassification occurred 30% more frequently in women (7.6%, 68/893) compared to men (5.7%, 34/593) and demonstrated higher rates of major adverse cardiac events (MACEs), coronary artery disease, and cerebrovascular disease. Among reclassified men, myocardial infarction (MI) was more often followed by death. Among women, reclassification was associated with MI or death, but rarely both. Time to first post-ED MACE was significantly longer in reclassified patients. In a Cox regression model, reclassification independently predicted a 52.5% lower hazard of MACE over time (P = 0.016). The regression model also described Class 1 obesity as protective, with a 68.2% hazard reduction vs normal weight (P < 0.001).
Conclusions
Integration of sex-specific URLs and a hs-cTnI assay identified patients at increased cardiovascular risk, yet was associated with improved long-term outcomes, suggesting potential clinical value. Findings also reinforce the obesity paradox, with Class 1 obesity linked to reduced MACE risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Science, University of Texas Medical Branch, Galveston, TX, United States.
ORCID-Profile: Michelle N Steiner, Juan U Rojo
Zitieren
APA
Steiner, M. N., Vyas, N. B., Rojo, J. U., & Esani, M. (2026). High-Sensitivity Cardiac Troponin I and Clinical Outcomes of Major Acute Cardiac Events. The Journal of Applied Laboratory Medicine, 11(4), 696-708. https://doi.org/10.1093/jalm/jfag035
Vancouver
Steiner MN, Vyas NB, Rojo JU, Esani M. High-Sensitivity Cardiac Troponin I and Clinical Outcomes of Major Acute Cardiac Events. The Journal of Applied Laboratory Medicine. 2026;11(4):696-708. doi:10.1093/jalm/jfag035
BibTeX
@article{Steiner2026,
author = {Steiner, Michelle N and Vyas, Niti B and Rojo, Juan U and Esani, Muneeza},
title = {High-Sensitivity Cardiac Troponin I and Clinical Outcomes of Major Acute Cardiac Events},
journal = {The Journal of Applied Laboratory Medicine},
year = {2026},
volume = {11},
number = {4},
pages = {696--708},
doi = {10.1093/jalm/jfag035}
}
EUVIMED